Ganoderma research papers

Of the total number of 7 species of this genus known in Europe, within the researches in the Republic of Macedonia, the following 6 species have been recorded: Ganoderma adspersum, G. applanatum, G. carnosum, G. lucidum, G. pfeifferi and G. resinaceum. G. pfeifferi is a new taxon for Macedonia.

Ganoderma lucidum (Reishi) in cancer treatment The popular edible mushroom Ganoderma lucidum (Reishi) has been widely used for the general promotion of health and longevity in Asian countries. The dried powder of Ganoderma lucidum was popular as a cancer chemotherapy agent in ancient China.

Reishi ( Ganoderma lucidum) is one of the primary herbs of choice in any immune deficiency disease. It possesses a broad spectrum of immunostimulating activities, as well as anti-inflammatory and antiallergenic properties. Reishi contains more than 100 oxygenated triterpenes, many of which exhibit a marked effect on the activity of NK cells.

G. lucidum polysaccharide (GLPS) has been identified as one of the major bioactive components and developed into a drug named “Ji 731 Injection” in China since 1973. The large-scale production of the drug began in 1985 and approved by the Chinese FDA as “Polysacharidum of G. lucidum Karst Injection in 2000, which is applied intramuscularly.